natgillin/translations-raw huggingface dataset:
Date of first authorisation: 23 April 2018 
Datum prve odobritve: 23. april 2018
Do not give this medicine to children and adolescents below the age of 18 years. 
Tega zdravila ne dajajte otrokom in mladostnikiom, mlajšim od 18 let.
IMPORTANT: Do not perform steps 2 to 5 too quickly. 
POMEMBNO: korakov od 2 do 5 ne opravite prehitro.
PC: {number} SN: {number} NN: {number} 
PC: {številka} SN: {številka}
These improvements were statistically significant (p < 0.001). 
Ta izboljšanja so bila statistično značilna (p < 0,001).
You should clean your inhaler once a week. 
Inhalator morate očistiti enkrat na teden.
If your breathing gets worse: 
Če se vam dihanje poslabša:
• growth retardation in children and adolescents. 
• zastoj v rasti pri otrocih ali mladostnikih.
(<1/10,000) and not known (cannot be estimated from available data). 
(<1/10.000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
Do not double the dose. 
Ne vzemite dvojnega odmerka.
Inspiratory Capacity (IC) 
Inspiratorna kapaciteta (IC - inspiratory capacity)
Your doctor may wish to carry out some blood tests. 
Zdravnik bo morda želel opraviti nekatere krvne preiskave.
Similar improvements, although not statistically significant, were observed at weeks 26 and 52. 
Podobna izboljšanja so opazili v 26. in 52. tednu, čeprav niso bila statistično pomembna.
ZA des Gailletrous 41260 La Chaussée Saint Victor France 
ZA des Gailletrous 41260 La Chaussée Saint Victor Francija
Other in-use storage times and conditions are under the responsibility of the user. 
Za drugačne čase in pogoje shranjevanja je odgovoren uporabnik.
See also section 4, “Possible side effects”. 
Glejte tudi poglavje 4, "Možni neželeni učinki".
These events are more likely to occur in children. 
Ti neželeni učinki se pogosteje pojavijo pri otrocih.
If it is almost time for your next dose, do not take the dose you have missed, but just take the next dose at the correct time. 
Če je že skoraj čas za naslednji odmerek, ne uporabite pozabljenega odmerka, ampak preprosto pravočasno uporabite naslednji odmerek.
• feeling worried, nervous, over-excited or irritable. 
• občutek zaskrbljenosti, živčnost, prevelika vznemirjenost ali razdražljivost.
See section 4.4 and section 5.2. 
Glejte poglavje 4.4 in poglavje 5.2.
Tell your doctor if you have any of these symptoms. 
Zdravniku morate povedati, če imate katerega od teh simptomov.
The two studies included approximately 20% of patients who used the AeroChamber Plus spacer. 
Ti dve študiji sta vključevali približno 20 % bolnikov, ki so uporabljali nastavek AeroChamber Plus.
In addition, two Phase IIIb studies were conducted to support the clinical efficacy and safety of Riarify. 
Izvedli so tudi dve študiji faze IIIb v podporo klinični učinkovitosti in varnosti zdravila Riarify.
Do not exceed your prescribed dose without talking to your doctor. 
Ne prekoračite predpisanega odmerka, ne da se pogovorite z zdravnikom.
The Phase III clinical development programme in COPD included two 52-week active-controlled studies. 
Faza III kliničnega razvojnega programa pri KOPB je vključevala dve 52-tedenski študiji z aktivno kontrolo.
However, available safety data from long-term clinical studies have not raised any significant safety concerns (see section 5.1). 
Vendar pa razpoložljivi podatki o varnosti iz dolgoročnih kliničnih študij niso dali povoda za znatne pomisleke glede varnosti (glejte poglavje 5.1).
Absorption, distribution and biotransformation 
Absorpcija, porazdelitev in biotransformacija
• formoterol fumarate dihydrate and 
• formoterolijev fumarat dihidrat in
Both studies were conducted in a similar population of COPD patients as studies TRILOGY and TRINITY. 
Obe študiji so izvedli s podobno populacijo bolnikov s KOPB kot študiji TRILOGY in TRINITY.
These patients should be monitored for potential adverse reactions. 
Te bolnike je treba spremljati zaradi možnih neželenih učinkov.
Tell your doctor immediately 
Nemudoma obvestite zdravnika:
Therefore, it is important that the patient is reviewed regularly. 
Zato so redni pregledi bolnikov pomembni.
The number of puffs remaining is displayed in intervals of 20. 
Število preostalih vdihov je prikazano v interavlih po 20.
infusion (6420 L versus 323 L), reflecting the slower elimination after inhalation. 
infundiranjem (6.420 l v primerjavi s 323 l), kar kaže na počasnejše izločanje po inhalaciji.
Prevention of oropharyngeal infections 
Preprečevanje orofaringealnih okužb
• sleep disorders (sleeping too little or too long) 
• motnje spanja (premalo ali preveč spanja);
There is no experience with or evidence of safety issues on the use of the propellant norflurane (HFA134a) during human pregnancy or lactation. 
Pri ljudeh ni izkušenj ali dokazov o varnosti uporabe pogonskega plina norflurana (HFA134a) med nosečnostjo ali dojenjem.
Prior to dispensing: Store in a refrigerator (2°C-8°C). 
Pred izdajo zdravila: Shranjujte v hladilniku (2 °C-8 °C).
If they are administered for compelling reasons, the effect of formoterol will be reduced or abolished. 
Če se dajejo zaradi nujnih razlogov, se učinek formoterola zmanjša ali izniči.
Some medicines may increase the effects of Riarify and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat). 
Nekatera zdravila lahko povečajo učinke zdravila Riarify in zdravnik vas bo morda želel skrbno spremljati, če jemljete ta zdravila (vključno z nekaterimi zdravili za zdravljenje okužbe z virusom HIV: ritonavirjem, kobicistatom).
Do not use this medicine after the expiry date which is stated on the label and carton after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki in škatli poleg oznake »EXP«.
Caution is also recommended when a number of reliever bronchodilators are used. 
Previdnost se priporoča tudi pri uporabi številnih olajševalnih bronhodilatatorjev.
• if you have difficulty passing urine. 
• če imate težave z odvajanjem urina;
If your COPD gets worse: 
Če se vam KOPB poslabša:
SPECIAL STORAGE CONDITIONS Prior to dispensing: 
POSEBNA NAVODILA ZA SHRANJEVANJE Pred izdajo zdravila:
However, studies on the effect of HFA134a on the reproductive function and embryofoetal development in animals revealed no clinically relevant adverse effects. 
Vendar pa študije učinka HFA134a na sposobnost razmnoževanja in razvoj zarodka/plodu pri živalih niso pokazale klinično pomembnih neželenih učinkov.
The steps below should be followed. 
Sledi naj naslednjim korakom.
Glucuronide acid conjugate is inactive. 
Konjugat glukuronidne kisline je neaktiven.
Plasma protein binding is moderately high. 
Vezava na beljakovine v plazmi je zmerno visoka.
• increased cough or increased breathing difficulties. 
• močnejši kašelj ali več težav z dihanjem.
Using Riarify together with: 
Uporaba zdravila Riarify skupaj z:
At least 65% of the fraction that is swallowed is absorbed from the gastrointestinal tract. 
Vsaj 65 % zaužitega deleža se absorbira iz prebavil.
The recommended dose is two puffs in the morning and two puffs in the evening. 
Priporočeni odmerek je dva vdiha zjutraj in dva vdiha zvečer.
They act in different ways to relax the muscles in your airways, helping to open the airways wider and allowing you to breathe more easily. 
Na različne načine delujeta tako, da sprostita mišice dihalnih poti, jih pomagata odpreti in vam omogočita, da lažje dihate.
• increased sweating 
• povečano znojenje;
• abnormal or reduced sense of taste 
• nenormalen ali zmanjšan okus;
On average, 8% and 25% of the dose was excreted as unchanged and total formoterol, respectively. 
Povprečno se je 8 % oz. 25 % odmerka izločilo kot nespremenjen in skupni formoterol.
Your doctor will assess your symptoms and if necessary may start you on a different treatment. 
Zdravnik bo ocenil vaše simptome in morda uvedel drugačno zdravljenje.
• decreased appetite 
• zmanjšan apetit;
Component of a multipack, cannot be sold separately. 
Sestavni del pakiranja z več enotami ni za posamično prodajo.
Caution should also be exercised when treating patients with known or suspected prolongation of the QTc interval (QTc > 450 milliseconds for males, or > 470 milliseconds for females), either congenital or induced by medicinal products as these patients were excluded from clinical trials with Riarify. 
Previdnost je potrebna tudi pri zdravljenju bolnikov z znanim podaljšanjem intervala QTc ali sumom nanj (QTc > 450 milisekund za moške ali > 470 milisekund za ženske), bodisi prirojenim ali povzročenim z zdravili, saj so bili ti bolniki izključeni iz kliničnih preskušanj z zdravilom Riarify.
It is unknown whether formoterol or glycopyrronium (including their metabolites) pass into human breast-milk but they have been detected in the milk of lactating animals. 
Ni znano, ali formoterol ali glikopironij (vključno z njunimi presnovki) prehajata v materino mleko, a so ju zaznali v mleku živalih v laktaciji.
The aerosol particles of Riarify are on average much smaller than the particles delivered in non-extrafine formulations. 
Aerosolni delci zdravila Riarify so povprečno veliko manjši kot delci v formulacijah, ki niso v obliki izredno majhnih delcev.
If patients find the treatment ineffective, they should continue treatment but medical attention must be sought. 
Če bolniki menijo, da zdravljenje ni učinkovito, naj z zdravljenjem nadaljujejo, vendar naj poiščejo medicinski nasvet.
In such a situation, your doctor may need to increase your dose of corticosteroids to cope with the stress and may prescribe them as tablets or injections. 
V tem primeru lahko zdravnik vaš odmerek kortikosteroidov poveča za obvladovanje stresa in vam predpiše v obliki tablet ali injekcij.
Contact your doctor if you experience blurred vision or other visual disturbances. 
Obvestite svojega zdravnika, če se pojavijo zamegljen vid ali druge motnje vida.
Check the dose counter or dose indicator. 
Preverite števec ali kazalnik odmerkov.
Using high-dose inhaled corticosteroids over a long time can cause in very rare cases effects on the body: 
Dolgotrajna uporaba visokoodmernih inhaliranih kortikosteroidov lahko v zelo redkih primerih povzroči sistemske učinke na telo:
There is a theoretical potential for interaction in particularly sensitive patients taking disulfiram or metronidazole. 
Obstaja teoretična možnost za interakcije, zlasti pri občutljivih bolnikih, ki jemljejo disulfiram ali metronidazol.
• stomach discomfort after meals 
• nelagodje v želodcu po obroku;
The apparent volume of distribution (Vz) of inhaled glycopyrronium was increased compared to intravenous (i.v.) 
Navidezni volumen porazdelitve (Vz) inhaliranega glikopironija se je povečal v primerjavi z intravenskim (i.v.)
Sudden and progressive deterioration in the symptoms of COPD is potentially life-threatening and the patient should undergo urgent medical assessment. 
Nenadno in napredujoče slabšanje simptomov KOPB je lahko življenjsko ogrožajoče, zato mora bolnika nujno pregledati zdravnik.
The clinical development programme of Riarify was conducted in patients with moderate, severe or very severe COPD. 
Klinični razvojni program zdravila Riarify so izvedli pri bolnikih z zmerno, hudo ali zelo hudo KOPB.
• if you are being, or have ever been, treated for tuberculosis (TB) or if you have a chest infection. 
• če se zdravite ali ste se kadar koli v preteklosti zdravili zaradi tuberkuloze (TB) ali če imate kakšno znano okužbo prsnega koša;
67% of an oral dose of formoterol is excreted in urine (mainly as metabolites) and the remainder in the faeces. 
Skupaj 67 % peroralnega odmerka formoterola se izloči v urinu (pretežno kot presnovki) in preostanek v blatu.
In addition, L-dopa, L-thyroxine, oxytocin and alcohol can impair cardiac tolerance towards beta2-sympathomimetics. 
Poleg tega lahko L-dopa, L-tiroksin, oksitocin in alkohol zmanjšajo toleranco srca za simpatikomimetike beta2.
If you feel that the medicine is not very effective, talk to your doctor. 
Če menite, da zdravilo ni zelo učinkovito, se posvetujte z zdravnikom.
Possible side effects are listed below according to their frequency. 
Možni neželeni učinki so našteti spodaj, in sicer po pogostnosti pojavljanja.
The bronchodilating effect sets in rapidly, within 1-3 minutes after inhalation, and has a duration of 12 hours after a single dose. 
Bronhodilatacijski učinek se pojavi hitro, od 1 do 3 minut po inhalaciji, in traja 12 ur po uporabi odmerka.
If you have a weak grip, it may be easier to hold the inhaler with both hands: hold the upper part of the inhaler with both index fingers and its lower part with both thumbs. 
Če imate šibak prijem, boste inhalator morda lažje držali z obema rokama - primite zgornji del inhalatorja z obema kazalcema in spodnji del z obema palcema.
The mean elimination half-life of glycopyrronium in healthy volunteers was approximately 6 hours after i.v. 
Izločanje Povprečni razpolovni čas izločanja glikopironija pri zdravih prostovoljcih je bil približno 6 ur po i.v.
If overdose occurs, the patient's symptoms should be treated supportively with appropriate monitoring as necessary. 
Če pride do prevelikega odmerjanja je treba bolnikove simptome zdraviti podporno in bolnika ustrezno spremljati, kot je potrebno.
It is recommended that treatment with Riarify should not be stopped abruptly. 
Priporoča se, da se zdravljenja z zdravilom Riarify ne prekine nenadoma.
You should only use Riarify during pregnancy if you are advised to do so by your doctor. 
Zdravilo Riarify uporabljajte med nosečnostjo le, če vam tako svetuje zdravnik.
If you see 'mist' coming from the top of the inhaler or the sides of your mouth, this means that Riarify will not be getting into your lungs as it should. 
Če opazite, da z vrha inhalatorja ali ob robu ust uhaja »meglica«, to pomeni, da zdravilo Riarify ne bo prišlo v vaša pljuča tako, kot bi moralo.
Elderly No dosage adjustment is required in elderly patients (65 years of age and older). 
Starejši Pri starejših bolnikih (starih 65 let ali več) odmerka ni treba prilagajati.
Related to formoterol 
V povezavi s formoterolom
If anaesthesia with halogenated anaesthetics is planned, it should be ensured that Riarify is not administered for at least 12 hours before the start of anaesthesia as there is a risk of cardiac arrhythmias. 
Če je načrtovana anestezija s halogeniranimi anestetiki, je treba zagotoviti, da se zdravilo Riarify ne uporabi vsaj 12 ur pred začetkom anestezije, saj obstaja tveganje srčnih aritmij.
If you are allergic to beclometasone dipropionate, formoterol fumarate dihydrate and glycopyrronium or to any of the other ingredients of this medicine (listed in section 6). 
Če ste alergični na beklometazondipropionat, formoterolijev fumarat dihidrat in glikopironij ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
See also section 4.4. 
Glejte tudi poglavje 4.4.
• changes in the electrocardiogram (heart trace) 
• spremembe na elektrokardiogramu (posnetek delovanja srca);
The toxicological profile of the triple combination reflected that of the single active components without a relevant increase in toxicity and without unexpected findings. 
Toksikološki profil trojne kombinacije je bil enak kot pri posamičnih učinkovinah brez pomembnega povečanja toksičnosti ali nepričakovanih izsledkov.
Patients should be advised to get a new inhaler when the dose counter or indicator shows the number 20. 
Bolniku je treba svetovati, da si priskrbi nov inhalator, ko števec ali kazalnik odmerkov kaže številko 20.
There are no relevant data on the use of Riarify in patients with severe hepatic impairment and the medicinal product should be used with caution in these patients (see section 4.4 and section 5.2). 
Relevantnih podatkov o uporabi zdravila Riarify pri bolnikih s hudo okvaro jeter ni, zato je treba zdravilo pri teh bolnikih uporabljati previdno (glejte poglavje 4.4 in poglavje 5.2).
• if you have low blood levels of potassium (hypokalaemia). 
• če imate nizko raven kalija v krvi (hipokaliemijo).
For instructions for use, see section 6.6. 
Za navodila o uporabi glejte poglavje 6.6.
There is an approximately linear increase in systemic exposure with increasing inhaled dose. 
Povečanje sistemske izpostavljenosti je približno linearno z večanjem inhaliranega odmerka.
• if you have narrowing of the arteries (also known as arteriosclerosis), if you have high blood pressure or if you have an aneurysm (abnormal bulging of the blood vessel wall). 
• če imate zožitev arterij (imenovana tudi kot arterioskleroza), če imate visok krvni tlak ali če imate anevrizmo (nenormalno razširjen del krvne žile);
Concomitant use of other beta-adrenergic medicinal products can have potentially additive effects; therefore, caution is required when other beta-adrenergic medicinal products are prescribed concomitantly with formoterol. 
Sočasna uporaba drugih beta-adrenergičnih zdravil ima lahko aditivni učinek, zato je pri predpisovanju drugih beta-adrenergičnih zdravil sočasno s formoterolom potrebna previdnost.
Therefore, blood glucose should be monitored during treatment following established guidelines in patients with diabetes. 
Zato je treba med zdravljenjem spremljati ravni glukoze v krvi po uveljavljenih smernicah za bolnike s sladkorno boleznijo.
Do not use this medicine to treat a sudden attack of breathlessness or wheezing. 
Tega zdravila ne uporabljajte za zdravljenje nenadnih napadov kratke sape ali piskajočega dihanja.
Riarify does not contain a high-dose inhaled corticosteroid, but your doctor may wish to measure the cortisol levels in your blood from time to time. 
Zdravilo Riarify ne vsebuje velikih odmerkov inhalacijskih kortikosteroidov, vendar bo morda zdravnik želel občasno izmeriti raven kortizola v krvi.
Patients should be informed about the signs and symptoms of acute narrow-angle glaucoma and should be informed to stop using Riarify and to contact their doctor immediately should any of these signs or symptoms develop. 
Bolnike je treba obvestiti o znakih in simptomih akutnega glavkoma z zaprtim zakotjem in jim naročiti, naj prenehajo uporabljati zdravilo Riarify in se takoj posvetujejo z zdravnikom, če se pojavijo ti znaki ali simptomi.
Your COPD may be getting worse and your doctor may need to prescribe different treatment. 
Morda se vam KOPB slabša in vam bo moral zdravnik predpisati kakšna druga zdravila.
This may be obtained by the patients using the AeroChamber Plus by one continuous slow and deep breath through the spacer, without any delay between actuation and inhalation. 
Bolnik lahko to doseže z nastavkom AeroChamber Plus v enem stalnem počasnem in globokem vdihu skozi nastavek in brez prekinitev med sprožitvijo in inhalacijo.
Do not pierce the pressurised container. 
Vsebnika pod tlakom ne smete prebosti.
The inhalation of formoterol may cause a rise in blood glucose levels. 
Inhaliranje formoterola lahko povzroči povišanje ravni glukoze v krvi.
At the same time, patients should breathe in slowly and deeply through the mouth until the lungs are full of air (this should take approximately 4 - 5 seconds). 
Istočasno naj bolnik počasi in globoko vdihne skozi usta, da se pljuča napolnijo z zrakom (to naj traja približno 4-5 sekund).
• if you have an infection of the mouth or throat. 
• če imate okužbo ust ali žrela.
• unusually fast heart beat and disorders of the heart rhythm 
• neobičajno hiter srčni utrip in motnje srčnega ritma;
• if you are due to have an anaesthetic. 
• če boste morali dobiti katerega od anestetikov.
Glycopyrronium has a quaternary ammonium structure which limits its passage across biological membranes and produces slow, variable and incomplete gastrointestinal absorption. 
Glikopironij ima strukturo kvarternega amonija, kar omejuje njegovo prehajanje skozi biološke membrane in povzroči počasno, spremenljivo in nepopolno absorpcijo v prebavilih.
Safety pharmacology 
Farmakologija varnosti
Do not use this medicine with a beta-blocker medicine (used for treating certain heart problems such as angina or for reducing blood pressure) unless your doctor has chosen a beta-blocker that does not affect your breathing. 
Tega zdravila ne uporabljajte z antagonisti adrenergičnih receptorjev beta (uporabljajo se za zdravljenje nekaterih težav s srcem, kot je angina pektoris, ali za zmanjševanje krvnega tlaka), razen če je zdravnik izbral antagonista adrenergičnih receptorjev beta, ki ne vpliva na vaše dihanje.
It is recommended that serum potassium levels are monitored in such situations. 
V takih situacijah se priporoča nadziranje serumske koncentracije kalija.
Systemic effects may occur with any inhaled corticosteroid, particularly at high doses prescribed for long periods. 
Pri vseh inhalacijskih kortikosteroidih se lahko pojavijo sistemski učinki, zlasti ob visokih odmerkih, ki se jih jemlje dolgo časa.
The patient should be advised to read the Package Leaflet carefully and follow the instructions for use as given in the leaflet. 
Bolniku je treba svetovati, da natančno prebere Navodilo za uporabo in sledi napotkom v navodilu.
Riarify is not indicated for the treatment of acute episodes of bronchospasm, or to treat an acute COPD exacerbation (i.e. as a rescue therapy). 
Zdravilo Riarify ni indicirano za zdravljenje akutnih epizod bronhospazmov ali za zdravljenje akutnega poslabšanja KOPB (tj. kot rešilno zdravljenje) ni.
Riarify is available in three container sizes: 
Zdravilo Riarify je na voljo v treh velikostih vsebnika:
Particular caution is advised in severe COPD as this effect may be potentiated by hypoxia. 
Posebna pozornost se svetuje pri hudi obliki KOPB, ker lahko hipoksija stopnjuje ta učinek.
Genotoxicity of Riarify has not been evaluated, however, the single active components were devoid of genotoxic activity in the conventional test systems. 
Genotoksičnosti zdravila Riarify niso ocenili, vendar pa posamične učinkovine v običajnih testnih sistemih niso kazale genotoksične dejavnosti.
Depending on the type of anaesthetic, it may be necessary to stop using Riarify at least 12 hours before the anaesthesia. 
Odvisno od vrste anestetika boste morda morali uporabo zdravila Riarify prekiniti vsaj 12 ur pred anestezijo;
Non-cardioselective beta-blockers (including eye drops) should be avoided in patients taking inhaled formoterol. 
Nekardioselektivnim zaviralcem beta adrenergičnih receptorjev (vključno s kapljicami za oko) se je treba pri bolnikih, ki uporabljajo inhalacijski formoterol, izogniti.
Paradoxical bronchospasm may occur with an immediate increase in wheezing and shortness of breath after dosing. 
Paradoksni bronhospazem se lahko pojavi s takojšnjim poslabšanjem piskajočega dihanja in kratke sape po odmerjanju.
Both studies were conducted in patients with a clinical diagnosis of COPD with severe to very severe airflow limitation (FEV1 less than 50% predicted), with symptoms assessed as a COPD Assessment Test (CAT) score of 10 or above, and with at least one COPD exacerbation in the previous year. 
obe navedeni študiji so bili vključeni bolniki s klinično diagnozo KOPB s hudo do zelo hudo omejitvijo pretoka zraka (FEV1 manj kot 50 % predvidenega) s simptomi, ocenjenimi z oceno 10 ali več po testu za oceno KOPB (CAT, COPD Assessment Test) in z najmanj enim poslabšanjem KOPB v preteklem letu.
However, in a 104-week rat inhalation carcinogenicity study and an oral 26-week carcinogenicity study in transgenic Tg.rasH2 mice, glycopyrronium bromide showed no carcinogenic potential and published data concerning long-term studies conducted with beclometasone dipropionate and formoterol fumarate in rats do not indicate a clinically relevant carcinogenic potential. 
Vendar pa v 104-tedenski študiji kancerogenosti pri podganah z inhaliranjem in peroralni 26-tedenski študiji kancerogenosti pri transgeni miši Tg.rasH2 glikopironijev bromid ni pokazal kancerogenega potenciala, objavljeni podatki v zvezi z dolgoročnimi študijami, izvedenimi z beklometazondipropionatom in formoterolijevim fumaratom pri podganah pa ne kažejo klinično pomembnega kancerogenega potenciala.
Tell your doctor if you have used more Riarify than you should and if you experience any of these symptoms. 
Zdravniku povejte, če ste uporabili več zdravila Riarify, kot bi smeli, in imate katerega od teh simptomov.
TDI was only measured in study TRILOGY. 
TDI so merili le v študiji TRILOGY.
After dispensing: 
Po izdaji: